01.12.2016 • News

Borealis Awards PDH Feasibility Study to Jacobs

(c) Borealis
(c) Borealis

Polyolefins producer Borealis has awarded a contract to Jacobs Engineering to carry out a feasibility study for its proposed second propane dehydrogenation (PDH) at Kallo in Belgium. The value of the contract was not disclosed. As part of the study, Jacobs is preparing a front-end-loading stage 2 conceptual design package for the outside battery limit areas of the plant. It is also complementing the process design package for the inside battery limit areas, which is being prepared by technology provider Honeywell UOP.

The study is scheduled to complete by mid-2017. The plant’s targeted annual capacity is 740,000 t and start-up has been potentially set for the second half of 2021. A final investment decision is expected in the third quarter of 2018. Jacobs’ senior vice president chemicals, Mark Bello, said the contract award is the result of its long-standing relationship with Borealis as well as its previous experience of working at the Kallo site.

Separately, Borealis has signed a Memorandum of Understanding (MoU) with Algerian industrial group Asmidal to evaluate opportunities to jointly develop a melamine plant in Algeria. A feasibility study will be performed in the coming months with a final investment decision expected during 2017. Borealis is Europe’s second largest producer of melamine, behind Dutch group, OCI Melamine.

Interview

Leading Transformation
The Path to Sustainable Growth

Leading Transformation

As Executive Vice President of International Chemicals since early 2024, Antje Gerber has been steering Sasol through a pivotal reset—focused on resilience, innovation, and bold sustainability goals.

Expert Insights

Dual‑Targeting Breakthroughs
Advancements in Bispecific Antibody Development

Dual‑Targeting Breakthroughs

Unlock the latest breakthroughs in bispecific antibody development! Download Wiley’s free Expert Insights eBook to explore cutting-edge dual-targeting strategies, advanced purification methods, and bioanalytical technologies transforming immunotherapy and cancer treatment.

most read